WallStSmart

Medirom Healthcare Technologies Inc (MRM)vsSea Ltd (SE)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Sea Ltd generates 244% more annual revenue ($27.72B vs $8.07B). SE leads profitability with a 5.9% profit margin vs 0.5%. MRM trades at a lower P/E of 0.9x. SE earns a higher WallStSmart Score of 60/100 (C+).

MRM

Hold

41

out of 100

Grade: D

Growth: 4.0Profit: 4.5Value: 8.3Quality: 4.0
Piotroski: 3/9Altman Z: 0.93

SE

Buy

60

out of 100

Grade: C+

Growth: 8.7Profit: 5.5Value: 7.3Quality: 6.5
Piotroski: 6/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MRMUndervalued (+70.1%)

Margin of Safety

+70.1%

Fair Value

$4.35

Current Price

$0.36

$3.99 discount

UndervaluedFair: $4.35Overvalued
SEUndervalued (+55.2%)

Margin of Safety

+55.2%

Fair Value

$255.67

Current Price

$75.18

$180.49 discount

UndervaluedFair: $255.67Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRM4 strengths · Avg: 9.0/10
P/E RatioValuation
0.9x10/10

Attractively priced relative to earnings

Return on EquityProfitability
63.9%10/10

Every $100 of equity generates 64 in profit

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

EPS GrowthGrowth
27.8%8/10

Earnings expanding 27.8% YoY

SE4 strengths · Avg: 8.8/10
Revenue GrowthGrowth
48.1%10/10

Revenue surging 48.1% year-over-year

Market CapQuality
$57.43B9/10

Large-cap with strong market position

PEG RatioValuation
0.998/10

Growing faster than its price suggests

Free Cash FlowQuality
$1.15B8/10

Generating 1.1B in free cash flow

Areas to Watch

MRM4 concerns · Avg: 3.0/10
Market CapQuality
$2.74M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.5%3/10

0.5% margin — thin

Debt/EquityHealth
1.753/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

SE3 concerns · Avg: 3.7/10
P/E RatioValuation
36.2x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Profit MarginProfitability
5.9%3/10

5.9% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MRM

The strongest argument for MRM centers on P/E Ratio, Return on Equity, Price/Book.

Bull Case : SE

The strongest argument for SE centers on Revenue Growth, Market Cap, PEG Ratio. Revenue growth of 48.1% demonstrates continued momentum. PEG of 0.99 suggests the stock is reasonably priced for its growth.

Bear Case : MRM

The primary concerns for MRM are Market Cap, Profit Margin, Debt/Equity. Debt-to-equity of 1.75 is elevated, increasing financial risk. Thin 0.5% margins leave little buffer for downturns.

Bear Case : SE

The primary concerns for SE are P/E Ratio, Altman Z-Score, Profit Margin.

Key Dynamics to Monitor

MRM profiles as a value stock while SE is a hypergrowth play — different risk/reward profiles.

SE carries more volatility with a beta of 1.55 — expect wider price swings.

SE is growing revenue faster at 48.1% — sustainability is the question.

SE generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

SE scores higher overall (60/100 vs 41/100) and 48.1% revenue growth. MRM offers better value entry with a 70.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medirom Healthcare Technologies Inc

CONSUMER CYCLICAL · PERSONAL SERVICES · USA

MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.

Visit Website →

Sea Ltd

CONSUMER CYCLICAL · INTERNET RETAIL · USA

Sea Limited is engaged in the digital entertainment, e-commerce and digital financial services businesses in Southeast Asia, Latin America, the rest of Asia and internationally. The company is headquartered in Singapore.

Want to dig deeper into these stocks?